Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (3782)	2/9/1998 10:53:00 AM
From: Oliver & Co	Respond to of 6136

Also, in my practice, the percentage of patients on PIs, has never been very high. I found years ago (even before 3TC), that other measures worked very well (albeit expensive). We gave patients infusions with high dose IVIG, Vit C, Leukovorin, MVI-12, and IM Injections of Vit B12, and Testosterone. And in the past 5 years I have only had about 3 patients die per year, and my hospitalization rate, has been the lowest in Dade County. (Until we had to stop the infussions in Nov, because of a national shortage, and since December my admission rate has gone up more than 300%. The point is, nobody has all the answers yet. As clinicians we can only offer the bast available treatment at the present time. And today, that includes the use of PI's.